Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$801,977
+$316,137 QoQ
Shares Held
11,488
-67.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#130
of 239 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. NKTR ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in NKTR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $801,977 | 11,488 | Shares | Defined | 2026-08-14 | |
| 2024-12-31 | $485,840 | 522,409 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $615,016 | 473,090 | Shares | Defined | 2024-11-14 | |
| 2022-09-30 | $36,427,907 | 11,383,721 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $43,258,139 | 11,383,721 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $61,358,256 | 11,383,721 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $153,794,070 | 11,383,721 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $204,451,629 | 11,383,721 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $195,344,652 | 11,383,721 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $227,674,420 | 11,383,721 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $227,674,404 | 13,392,612 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $251,385,714 | 15,152,846 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $350,908,298 | 15,151,481 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $281,083,232 | 15,746,960 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||